IP Library Assignment 020478/0544
Patent Assignment
Reel/Frame 020478/0544

Assignment of Assignor's Interest

Recorded: 2008-02-08 Pages: 31
Assignors
KEELING, P.N.W.
Executed: 2003-09-02
DINAN, TIMOTHY
Executed: 2006-02-16
Assignee
AGI THERAPEUTICS RESEARCH LIMITED
ADELAIDE CHAMBERS, PETER STREET, DUBLIN 8, IRELAND
Covered Property (1)
Treatment of Abnormal Increases in Gastrointestinal Motility with (R)-Verapamil
Patent: 6,849,661 →
Application: 10/294,692 →
Publication: US 2004/0063784
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Jun 19, 2012
From: AGI THERAPEUTICS RESEARCH LIMITED
To: VIDARA THERAPEUTICS RESEARCH LIMITED
Reel/Frame 028401/0563 →
Security Agreement Jun 19, 2012
From: AGI THERAPEUTICS PUBLIC LIMITED COMPANY; VIDARA THERAPEUTICS RESEARCH LIMITED
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028401/0688 →
Change of Name Jun 19, 2012
From: AGI THERAPEUTICS LIMITED
To: AGI THERAPEUTICS PUBLIC LIMITED COMPANY
Reel/Frame 028401/0655 →
Release of Security Interest Mar 17, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: VIDARA THERAPEUTICS RESEARCH LIMITED; AGI THERAPEUTICS, LTD. (F/K/A AGI THERAPEUTICS PLC)
Reel/Frame 032452/0237 →
Security Interest May 7, 2015
From: HORIZON PHARMA SERVICES LIMITED (FORMERLY KNOWN AS AGI THERAPEUTICS PUBLIC LIMITED COMPANY); HORIZON PHARMA IRELAND LIMITED (FORMERLY KNOWN AS VIDARA THERAPEUTICS RESEARCH LIMITED)
To: CITIBANK, N.A.
Reel/Frame 035590/0950 →
Change of Name Aug 12, 2015
From: VIDARA THERAPEUTICS RESEARCH LIMITED
To: HORIZON PHARMA IRELAND LIMITED
Reel/Frame 036309/0919 →
Change of Name Aug 12, 2015
From: AGI THERAPEUTICS LIMITED
To: HORIZON PHARMA SERVICES LIMITED
Reel/Frame 036309/0553 →
Release of Security Interest Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS IRELAND DAC (SUCCESSOR IN INTEREST TO HORIZON PHARMA SERVICES LIMITED); HORIZON THERAPEUTICS IRELAND DAC (FKA HORIZON PHARMA IRELAND LIMITED); HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.); HZNP LIMITED
Reel/Frame 065153/0953 →